Prostate cancer and additional malignancies grow slower in p50−/− mice or in p50f/f;LysM-Cre mice lacking p50 specifically in myeloid cells, associated with increased total and activated tumor T cells [8–12]. Here, NFKB1 is linked to prostate cancer.